CIK: 0001663801
Total reported value
$43.5M
Reporting period: 2024-09-30 · Number of holdings: 5
Bill & Melinda Gates Foundation disclosed 5 holdings in its latest 13F filing for the period ending 2024-09-30, with total reported value of $43.5M and a quarterly turnover rate of 0.0%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "B"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BNTX | Biontech Se-adr | Stock-Other | 40.59% | — | — | |
| 2 | VIR | Vir Biotechnology INC | Stock-Other | 26.84% | — | — | |
| 3 | EXAIEUR | Exscientia PLC | Stock-Other | 17.85% | — | — | |
| 4 | ✓ | Curevac N V | Stock-Other | 10.60% | — | -1.80% | |
| 5 | BFLY | Butterfly Network INC | Stock-Other | 4.11% | — | — |
Performance for Q3 2026
-3.2%
Performance Last 4 Quarters
+36.6%
Based on 72% of reported portfolio value with available pricing
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2024-09-30 | 5 | $43.5M | 0 | |
| 2024-06-30 | 5 | $40.2M | 0 | |
| 2024-03-31 | 8 | $84.1M | 0 | |
| 2023-12-31 | 8 | $89.9M | 0 | |
| 2023-09-30 | 9 | $83.9M | 0 | |
| 2023-06-30 | 9 | $125.6M | 0 | |
| 2023-03-31 | 9 | $113.2M | 0 | |
| 2022-12-31 | 9 | $129.8M | 0 | |
| 2022-09-30 | 10 | $126.5M | 0 | |
| 2022-06-30 | 9 | $130.1M | 0 | |
| 2022-03-31 | 11 | $186.0M | 0 | |
| 2021-12-31 | 11 | $329.6M | 0 | |
| 2021-09-30 | 10 | $341.6M | 0 | |
| 2021-06-30 | 8 | $650.8M | 0 | |
| 2021-03-31 | 7 | $611.1M | 0 | |
| 2020-12-31 | 5 | $437.8M | 0 |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-11-14 | Amendment | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-14 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-14 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-13 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-12 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-14 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-12 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-13 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-11 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-11-15 | Amendment | View on EDGAR |
| 2021-06-30 | 2021-08-13 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-11-15 | Amendment | View on EDGAR |
| 2021-03-31 | 2021-05-14 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001484040
Total reported value
$43.5M
7 stks
2024-12-31
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001841989
Total reported value
$43.5M
43 stks
2023-09-30
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001212897
Total reported value
$43.5M
25 stks
2022-12-31
Stale — no recent filing
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001131399
Total reported value
$599.2M
13 stks
2026-03-31
2 of the top 5 holdings overlap, including Biontech Se-adr
CIK 0001274403
Total reported value
$677.1M
10 stks
2026-03-31
1 of the top 5 holdings overlap, including Vir Biotechnology INC
CIK 0001316915
Total reported value
$20.0M
65 stks
2023-03-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Vir Biotechnology INC